CIK 0001752828
- Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831702591
- Phone
- +1 908-768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- 4 Grant or award Director acquired 199,921 shares (grant or award)
- 4 Grant or award Director acquired 199,921 shares (grant or award)
- 4 Grant or award Director acquired 199,921 shares (grant or award)
- 4 Shares withheld for taxes Pres, Functional Regeneration gave up 2,683 shares (to pay taxes)
- 4 Shares withheld for taxes Fletcher Kyle gave up 201 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 11,540 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,606 shares (to pay taxes)
- 4 Shares withheld for taxes Haines John R gave up 5,770 shares (to pay taxes)
- 4 Shares withheld for taxes Glover Bradley gave up 2,884 shares (to pay taxes)
- 4 Shares withheld for taxes Fletcher Kyle gave up 2,170 shares (to pay taxes)
- 4 Grant or award Chief Executive Officer acquired 2,084,854 shares (grant or award)
- 4 Grant or award Fletcher Kyle acquired 225,000 shares (grant or award)
- 4 Grant or award Senior Exec Vice President acquired 400,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 250,000 shares (grant or award)
- 4 Grant or award Glover Bradley acquired 300,000 shares (grant or award)
- 4 Grant or award Pres, Functional Regeneration acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 300,000 shares (grant or award)
- 4 Exercise or conversion Director acquired 1,071,000 shares (option exercise)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.72 ($17,175)
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at $1.71 ($68,400)
Page 5 of 10 · 191 filings